Candida auris: Epidemiology and Antifungal Strategy

Annual Review of Medicine · Published 2024-12-10 · DOI 10.1146/annurev-med-061523-021233

Authors being retrieved — see the publisher record. https://doi.org/10.1146/annurev-med-061523-021233

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2024

Related articles

• The urgent and challenging superbug fungus Candidozyma auris (formerly Candida auris): a comprehensive review · Antonie van Leeuwenhoek, International Journal of General and Molecular Microbiology · 2026 · Cites or is cited by this article
• NT-A9, a new triazole, exhibits potent antifungal activity against Candida and Cryptococcus species through potent ergosterol biosynthesis inhibition · Antimicrobial Agents and Chemotherapy · 2026 · Cites or is cited by this article
• New Oral Selective Estrogen Receptor Degraders Redefine Management of Estrogen Receptor–Positive Breast Cancer · Annual Review of Medicine · 2025 · Same journal
• CD70: An Emerging Anticancer Target in Renal Cell Carcinoma and Beyond · Annual Review of Medicine · 2024 · Same journal
• Emerging Long-Term Risks of the Use of Proton Pump Inhibitors and Potassium-Competitive Acid Blockers · Annual Review of Medicine · 2024 · Same journal
• Biologic Medications for Severe Asthma: Implications for Understanding Pathogenic Heterogeneity and Endotypes · Annual Review of Medicine · 2024 · Same journal
• Lessons from the Use of Monoclonal Antibodies to SARS-CoV-2 Spike Protein During the COVID-19 Pandemic · Annual Review of Medicine · 2024 · Same journal
• Advances in Therapy for Refractory Epilepsy · Annual Review of Medicine · 2024 · Same journal
• Approach to Therapy for Chronic Pouchitis · Annual Review of Medicine · 2025 · Same journal
• Cancer Neoantigen Vaccines Emerge Efficacious · Annual Review of Medicine · 2026 · Same journal